# Oral Sodium to Preserve Renal EfficiencY in Acute Heart Failure

> **NCT04334668** · NA · ACTIVE_NOT_RECRUITING · sponsor: **The Cleveland Clinic** · enrollment: 67 (actual)

## Conditions studied

- Volume Overload

## Interventions

- **DIETARY_SUPPLEMENT:** Oral Sodium Chloride
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04334668
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-05-20
- **Primary completion:** 2022-06-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04334668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04334668, "Oral Sodium to Preserve Renal EfficiencY in Acute Heart Failure". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04334668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*